Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
netFormulary
Home
Treatment Use
Class
Chapters
News
Reports
Contact
SEARCH
Searching for :
Tolvaptan
Open monograph to display formulary status.
Formulary items found
Status
Description
Section
RED
Tolvaptan Jinarc
®
/ Teva
(15/45mg, 30/60mg, 30/90mg tablets)
Endocrine system, Antidiuretic hormone antagonists, 06.05.02
RED
Tolvaptan Samsca
®
(7.5mg, 15mg, 30mg Tablets)
Endocrine system, Antidiuretic hormone antagonists, 06.05.02
Searchiing the National BNF we found these items - Click button under Local to search local formulary or BNF to view on online BNF.
Local
BNF
Section
Tolvaptan
Tolvaptan
Endocrine System, Diuretics, Selective Vasopressin V2-Receptor Antagonists
Antidiuretic Hormone Disorders, Syndrome Of Inappropriate Antidiuretic Hormone Secretion
Tolvaptan
Tolvaptan
Genito-Urinary System, Diuretics, Selective Vasopressin V2-Receptor Antagonists
Kidney Disorders
Links found
JPC bulletin 261: Tolvaptan (Samsca® Brand) tablets for the treatment of hyponatraemia secondary to the syndrome of inappropriate antidiuretic hormone secretion (SIADH) in patients not requiring chemotherapy (March 18)
NHS England: Tolvaptan for hyponatraemia secondary to the Syndrome of Inappropriate Antidiuretic Hormone (SIADH) in patients requiring cancer chemotherapy
NICE TA358: Tolvaptan for treating autosomal dominant polycystic kidney disease